Johan Frostegård
Swedish writer and scientist (born 1959)
From Wikipedia, the free encyclopedia
Johan Frostegård, born 1959, is a Swedish professor of medicine,[1] an inventor and a fiction and non-fiction writer.
Frostegård was born in Malmö, Sweden. He studied economics in Stockholm before pursuing a degree in medicine, later specializing in internal medicine and rheumatology. He received his PhD at Karolinska Institutet in 1992 and gained tenure as a professor there in 2003. He also holds a B.A. in the history of economics.[2]
The main focus of Frostegård's research is the role of the immune system in the development and treatment of cardiovascular diseases.[3]
Frostegård is a co-founder of four biotech startups: Athera Biotechnologies AB,[4] Medirista AB,[5] Medirista Biotechnologies AB[6] and Annexin Pharmaceuticals AB,[7] the latter being listed on Nasdaq First North since 2017.[8]
Frostegård has written five novels, four poetry collections and several popular science books,[9] centered around evolutionary perspectives on the humanities, economics and society.[10] He has also written articles for various Swedish newspapers and magazines,[11] notably opposing euthanasia.[12]
